Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02877095 · ClinicalTrials.gov registry record · Phase 1
Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot
A Phase 1 study of Acute Heart Failure, sponsored by Adrian Hernandez.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
- 5
- Study locations
NCT02877095 is a Phase 1 study of Acute Heart Failure that has completed, run by Adrian Hernandez. The registered enrollment target is 40 participants, below the 1,448-participant average among 8 other Acute Heart Failure trials with a reported enrollment target (97% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT02877095, a Phase 1 study of Acute Heart Failure, has completed, sponsored by Adrian Hernandez.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
- 5
- Study locations
Study Summary
The Pilot study is designed to evaluate the overall safety and feasibility of a strategy based on subcutaneous delivery of furosemide. It will be used to inform the subsequent evaluation phase of the study (separate protocol). The primary objective of the study is to determine if a strategy of a novel subcutaneous delivery of furosemide is safe and feasible in patients with acute heart failure.
Conditions Studied
Interventions
- DRUG Furosemide
Study Locations (5)
Georgia
- Emory University Hospital - Atlanta
Massachusetts
- Massachusetts General Hospital - Boston
Minnesota
- Mayo Clinic - Rochester
North Carolina
- Duke University Medical Center - Durham
Ohio
- Metro Health System - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-12-19 |
| Est. Completion | 2017-11-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02877095
The ClinicalTrials.gov registry entry for NCT02877095 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,448-participant average among 8 other Acute Heart Failure trials with a reported enrollment target (97% lower). The listed sponsor is Adrian Hernandez, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Furosemide is the first listed.
NCT02877095 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Georgia, Massachusetts, Minnesota.
Frequently Asked Questions
What is clinical trial NCT02877095 about?
NCT02877095 is a clinical study titled "Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot". The Pilot study is designed to evaluate the overall safety and feasibility of a strategy based on subcutaneous delivery of furosemide. It will be used to inform the subsequent evaluation phase of the study (separate protocol). The primary objective of the study is to determine if a strategy of a nov...
What is the current status of trial NCT02877095?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2016-12-19. Estimated completion is 2017-11-07.
What conditions does trial NCT02877095 study?
This clinical trial studies the following conditions: Acute Heart Failure.
What interventions are being tested in trial NCT02877095?
The interventions under investigation include: Furosemide (DRUG).
Who is sponsoring clinical trial NCT02877095?
This trial is sponsored by Adrian Hernandez, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02877095 being conducted?
This trial has 5 study locations across Georgia, Massachusetts, Minnesota, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
RECRUITING · Phase 3
-
Improving Diagnostic Accuracy for Acute Heart Failure
ACTIVE NOT RECRUITING
-
Randomized Controlled Trial of urinE chemiStry Guided aCute heArt faiLure treATmEnt (ESCALATE)
ACTIVE NOT RECRUITING · Phase 2
-
An Observational Study of the Functional Capacity of Heart Failure
COMPLETED · NA
-
Tezosentan in Acute Heart Failure
COMPLETED · Phase 3
-
Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.